Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Women with acne and hair loss, even if they have regular periods, often have polycystic ovary syndrome.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Screen young women with menstrual issues, acne, or excess hair for high cortisol to avoid misdiagnosis.

Spironolactone effectively treats female acne with few side effects.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Iraqi women with PCOS often have higher testosterone levels and obesity.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.